Alan Christy Hunter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alan Christy Hunter has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- Seyed Moein Moghimi
Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
42 shared publications - Andrew W. Lloyd
School of Pharmacy and Biomolecular Sciences, University of Brighton, Moulsecoomb, Brighton BN2 4GJ, UK
14 shared publications - Thomas Lars Andresen
Biotherapeutic Engineering and Drug Targeting, Department of Health Technology, Technical University of Denmark (DTU), Kgs. Lyngby, Denmark
10 shared publications Howard T. Dodd
University of Brighton, School of Pharmacy and Biomolecular Sciences, Huxley Building, Lewes Road, Brighton BN2 4GJ, UK
8 shared publicationsCinzia Dedi
University of Brighton, School of Pharmacy and Biomolecular Sciences, Huxley Building, Lewes Road, Brighton BN2 4GJ, United Kingdom
7 shared publications- Alina J. Andersen
Nanomedicine Research Group, Centre for Pharmaceutical Nanotechnology and Nanotoxicology, University of Copenhagen, Copenhagen Ø, Denmark
6 shared publications
Latest Publications
- 15 August 2017
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 9 (33) , 27544-27552
Quartz Crystal Microbalance Assay of Clinical Calcinosis Samples and Their Synthetic Models Differentiates the Efficacy of Chelation-Based Treatments
This paper sets out in vitro protocols for studying the relative effectiveness of chelators used in the dissolution-based treatment of hard calcinosis. Pulverized hard calcinosis samples from human donors or synthetic hydroxyapatite nanoparticles were deposited by electrophoretic deposition on the surface of a quartz crystal microbalance sensor. Over 150 deposits of N,N,N′,N′-tetraethylethylenediamine (TEEDA) showed no dissolution effect. Pharmaceutical dissolution testing of synthetic hydroxyapatite tablets over 6 h showed that EDTA dissolved the tablets four to nine times more quickly than citrate.
- 15 August 2017
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 9 (33) , 27544-27552
Quartz Crystal Microbalance Assay of Clinical Calcinosis Samples and Their Synthetic Models Differentiates the Efficacy of Chelation-Based Treatments
This paper sets out in vitro protocols for studying the relative effectiveness of chelators used in the dissolution-based treatment of hard calcinosis. Pulverized hard calcinosis samples from human donors or synthetic hydroxyapatite nanoparticles were deposited by electrophoretic deposition on the surface of a quartz crystal microbalance sensor. Over 150 deposits of N,N,N′,N′-tetraethylethylenediamine (TEEDA) showed no dissolution effect. Pharmaceutical dissolution testing of synthetic hydroxyapatite tablets over 6 h showed that EDTA dissolved the tablets four to nine times more quickly than citrate.
- 9 June 2017
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1862 (9) , 939-945
Metabolism of steroidal lactones by the fungus Corynespora cassiicola CBS 161.60 results in a mechanistically unique intramolecular ring-D cyclization resulting in C-14 spiro-lactones
- 9 June 2017
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1862 (9) , 939-945
Metabolism of steroidal lactones by the fungus Corynespora cassiicola CBS 161.60 results in a mechanistically unique intramolecular ring-D cyclization resulting in C-14 spiro-lactones
- 10 April 2017
- Published by Springer Nature in Nature Nanotechnology
- Vol. 12 (6) , 589-594
Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes
Intravenously injected nanopharmaceuticals, including PEGylated nanoparticles, induce adverse cardiopulmonary reactions in sensitive human subjects, and these reactions are highly reproducible in pigs. Although the underlying mechanisms are poorly understood, roles for both the complement system and reactive macrophages have been implicated. Here, we show the dominance and importance of robust pulmonary intravascular macrophage clearance of nanoparticles in mediating adverse cardiopulmonary distress in pigs irrespective of complement activation. Specifically, we show that delaying particle recognition by macrophages within the first few minutes of injection overcomes adverse reactions in pigs using two independent approaches. First, we changed the particle geometry from a spherical shape (which triggers cardiopulmonary distress) to either rod- or disk-shape morphology. Second, we physically adhered spheres to the surface of erythrocytes. These strategies, which are distinct from commonly leveraged stealth engineering approaches such as nanoparticle surface functionalization with poly(ethylene glycol) and/or immunological modulators, prevent robust macrophage recognition, resulting in the reduction or mitigation of adverse cardiopulmonary distress associated with nanopharmaceutical administration.
- 10 April 2017
- Published by Springer Nature in Nature Nanotechnology
- Vol. 12 (6) , 589-594
Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes
Intravenously injected nanopharmaceuticals, including PEGylated nanoparticles, induce adverse cardiopulmonary reactions in sensitive human subjects, and these reactions are highly reproducible in pigs. Although the underlying mechanisms are poorly understood, roles for both the complement system and reactive macrophages have been implicated. Here, we show the dominance and importance of robust pulmonary intravascular macrophage clearance of nanoparticles in mediating adverse cardiopulmonary distress in pigs irrespective of complement activation. Specifically, we show that delaying particle recognition by macrophages within the first few minutes of injection overcomes adverse reactions in pigs using two independent approaches. First, we changed the particle geometry from a spherical shape (which triggers cardiopulmonary distress) to either rod- or disk-shape morphology. Second, we physically adhered spheres to the surface of erythrocytes. These strategies, which are distinct from commonly leveraged stealth engineering approaches such as nanoparticle surface functionalization with poly(ethylene glycol) and/or immunological modulators, prevent robust macrophage recognition, resulting in the reduction or mitigation of adverse cardiopulmonary distress associated with nanopharmaceutical administration.
- 1 December 2016
- Published by Elsevier in Journal of Controlled Release
- Vol. 244, 24-29
AFM visualization of sub-50 nm polyplex disposition to the nuclear pore complex without compromising the integrity of the nuclear envelope
- 1 December 2016
- Published by Elsevier in Journal of Controlled Release
- Vol. 244, 24-29
AFM visualization of sub-50 nm polyplex disposition to the nuclear pore complex without compromising the integrity of the nuclear envelope
- 17 May 2016
- Published by Royal Society of Chemistry (RSC) in Polymer Chemistry
- Vol. 8 (1) , 41-51
Smart polymers in drug delivery: a biological perspective
Key to the widespread application of smart polymers in drug delivery is understanding the mechanistic interplay, as well as consequence, of the presence of these macromolecules within living systems.
- 17 May 2016
- Published by Royal Society of Chemistry (RSC) in Polymer Chemistry
- Vol. 8 (1) , 41-51
Smart polymers in drug delivery: a biological perspective
Key to the widespread application of smart polymers in drug delivery is understanding the mechanistic interplay, as well as consequence, of the presence of these macromolecules within living systems.
- 1 January 2016
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 12 (1) , 245-248
Platelet mimicry: The emperor's new clothes?
- 1 January 2016
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 12 (1) , 245-248
Platelet mimicry: The emperor's new clothes?
- 1 November 2015
- Published by Elsevier in Phytochemistry
- Vol. 119, 19-25
Metabolic fate of 3α,5-cycloandrostanes in the endogenous lactonization pathway of Aspergillus tamarii KITA
- 1 November 2015
- Published by Elsevier in Phytochemistry
- Vol. 119, 19-25
Metabolic fate of 3α,5-cycloandrostanes in the endogenous lactonization pathway of Aspergillus tamarii KITA
- 1 September 2013
- Published by Elsevier in Journal of Controlled Release
- Vol. 170 (2) , 167-174
Complement monitoring of Pluronic 127 gel and micelles: Suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins AI and B-100
- 1 September 2013
- Published by Elsevier in Journal of Controlled Release
- Vol. 170 (2) , 167-174
Complement monitoring of Pluronic 127 gel and micelles: Suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins AI and B-100
- 1 September 2013
- Published by Elsevier in International Immunopharmacology
- Vol. 17 (1) , 33-34
Surfactant-mediated complement activation in beagle dogs
- 1 September 2013
- Published by Elsevier in International Immunopharmacology
- Vol. 17 (1) , 33-34
Surfactant-mediated complement activation in beagle dogs
- 1 May 2013
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 9 (4) , 469-473
Complement activation by PEG-functionalized multi-walled carbon nanotubes is independent of PEG molecular mass and surface density
- 1 May 2013
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 9 (4) , 469-473
Complement activation by PEG-functionalized multi-walled carbon nanotubes is independent of PEG molecular mass and surface density